Demand is rising with targeted deficiency screening, preventive care and aging populations. Opportunities span lab outsourcing, automation, point-of-care and home testing, especially in Asia-Pacific.
Vitamin D Testing Market Vitamin D Testing Market Growth Rate By Region
Dublin, Aug. 20, 2026 (GLOBE NEWSWIRE) — “Vitamin D Testing – Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)” has been added to ResearchAndMarkets.com’s offering.
Vitamin D Testing Market to Reach USD 1.67 Billion by 2031, Growing at an 8.21% CAGR
The global vitamin D testing market is projected to grow from USD 1.04 billion in 2025 to USD 1.13 billion in 2026 before reaching USD 1.67 billion by 2031. The market is expected to register a compound annual growth rate of 8.21% from 2026 to 2031, supported by the rising prevalence of vitamin D deficiency, greater adoption of preventive healthcare, expanding diagnostic laboratory capacity, and increased testing among high-risk populations.
Rising Vitamin D Deficiency Drives Testing Demand
Approximately 1 billion people worldwide have inadequate vitamin D levels, creating sustained demand for clinical testing and long-term monitoring. Deficiency rates remain particularly high among certain demographic groups, including Black and Latino populations in the United States. Aging populations, limited sun exposure associated with urban lifestyles, malabsorption disorders, and chronic health conditions are also contributing to increased testing volumes.
Clinical guidelines published by the Endocrine Society in 2024 established more precise vitamin D testing criteria for high-risk groups. Although the guidelines discourage universal screening, they support targeted testing for patients with relevant risk factors. Healthcare providers are increasingly incorporating vitamin D assessment into chronic disease management programs for osteoporosis, diabetes, and cardiovascular conditions. Government surveillance connected with food-fortification initiatives is generating additional laboratory demand across several regions.
Preventive Healthcare and Routine Screening Support Market Growth
The shift toward preventive healthcare is strengthening the role of vitamin D testing in routine health assessments. Value-based reimbursement models encourage earlier detection and monitoring, while Medicare Advantage plans and a growing number of private insurers include vitamin D measurement in eligible preventive care programs.
Direct-to-consumer laboratory services are also expanding access by allowing individuals to order tests outside traditional physician-led pathways. Global direct-to-consumer laboratory spending is forecast to exceed USD 9 billion by 2033, indicating strong consumer interest in proactive health monitoring. Employers are adding vitamin D tracking to corporate wellness programs, while senior-care providers are integrating deficiency screening into fall-prevention and supplementation initiatives.
Additional market growth factors include greater laboratory automation, the emergence of reimbursement codes in the United States and Europe, and the development of rapid testing services. However, regulatory scrutiny involving direct-to-consumer health claims may affect how testing providers market their services.
Pricing Pressure Reshapes Laboratory Strategies
Bundled wellness panels are placing downward pressure on vitamin D test pricing. Insurers increasingly reimburse comprehensive screening panels at a single contracted rate, reducing margins for individual assays. Large national laboratories can use scale and automated workflows to manage these pressures, while regional and independent providers may face greater challenges in maintaining profitability.
Consumer testing platforms are contributing to price competition by promoting discounted multi-analyte panels. In response, laboratories are automating testing processes, renegotiating supplier agreements, and offering complementary allergy, hormone, and wellness panels. These strategies help providers improve operating efficiency and generate additional revenue while responding to demand for affordable diagnostic services.
Services Segment Gains Momentum
Reagents and kits accounted for 45.05% of the vitamin D testing market in 2025, maintaining the largest product-related revenue share. However, margins are tightening as automated systems reduce consumable use per assay. Instruments represent a smaller portion of market revenue, but analyzer installations create recurring demand for compatible reagents and testing supplies.
The services segment is forecast to expand at an 8.87% CAGR through 2031, driven by hospital outsourcing, reference laboratory consolidation, and increasing demand for specialized vitamin D panels. Laboratories that cannot justify major investments in automation are increasingly subcontracting tests to centralized service providers. Digital integration between analyzers and laboratory information systems is also creating new opportunities for diagnostic suppliers and service organizations.
Manufacturers are developing high-sensitivity reagents compatible with chemiluminescence immunoassay and LC-MS/MS platforms. Point-of-care models are gaining traction in primary-care settings, where faster results can support supplementation decisions during a single patient visit.
Asia-Pacific Emerges as the Fastest-Growing Regional Market
North America generated 41.80% of global vitamin D testing market revenue in 2025, supported by broad insurance coverage, established laboratory networks, and advanced automation infrastructure. Asia-Pacific is projected to record the fastest regional growth, with a 10.74% CAGR driven by urbanization, rising middle-class health awareness, and private investment in diagnostic services.
Laboratory networks in India are expanding into smaller cities, while demand in China is increasing alongside preventive health and nutraceutical trends. Europe is expected to grow steadily due to aging demographics and fortification-related surveillance, although reimbursement constraints may limit expansion. The Middle East and Africa also present emerging opportunities as governments modernize healthcare systems and address high vitamin D deficiency rates across their populations.
Key Topics Covered:
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising burden of vitamin-D deficiency diagnoses (mainstream)
4.2.2 Shift to preventive healthcare & routine screening (mainstream)
4.2.3 CLIA automation lowering per-test cost (mainstream)
4.2.4 Emerging reimbursement codes in Europe & U.S. (mainstream)
4.2.5 AI-enabled at-home micro-sample kits (under-the-radar)
4.2.6 National fortification policies prompting surveillance testing (under-the-radar)
4.3 Market Restraints
4.3.1 Pricing pressure from bundled wellness panels (mainstream)
4.3.2 Variability between assay methods (mainstream)
4.3.3 Dried-blood-spot sample stability concerns (under-the-radar)
4.3.4 Regulatory scrutiny over direct-to-consumer claims (under-the-radar)
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter’s Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts
5.1 By Product Type (Value)
5.1.1 Reagent & Kits
5.1.2 Instruments
5.1.3 Services
5.2 By Technology (Value)
5.2.1 LC-MS/MS
5.2.2 Chemiluminescence Immunoassay (CLIA)
5.2.3 ELISA
5.2.4 Radio-Immunoassay (RIA)
5.2.5 Others
5.3 By End User (Value)
5.3.1 Diagnostic Laboratories
5.3.2 Hospitals & Clinics
5.3.3 Home-care & Remote Testing
5.3.4 Others
5.4 By Sample Type (Value)
5.4.1 Serum / Plasma
5.4.2 Whole Blood
5.4.3 Dried Blood Spot
5.4.4 Others
5.5 By Geography (Value)
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 India
5.5.3.3 Japan
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 South America
5.5.4.1 Brazil
5.5.4.2 Argentina
5.5.4.3 Rest of South America
5.5.5 Middle East and Africa
5.5.5.1 GCC
5.5.5.2 South Africa
5.5.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 F. Hoffmann-La Roche AG
6.3.3 Siemens Healthineers AG
6.3.4 Danaher Corporation (Beckman Coulter)
6.3.5 Thermo Fisher Scientific Inc.
6.3.6 DiaSorin S.p.A.
6.3.7 Quest Diagnostics Incorporated
6.3.8 bioMerieux SA
6.3.9 Bio-Rad Laboratories Inc.
6.3.10 Ortho Clinical Diagnostics Holdings plc
6.3.11 Grifols S.A.
6.3.12 Randox Laboratories Ltd.
6.3.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.3.14 Tosoh Corporation
6.3.15 Sysmex Corporation
6.3.16 Eurofins Scientific SE
6.3.17 ARUP Laboratories
6.3.18 Cerba HealthCare SAS
6.3.19 Unilabs AB
6.3.20 Biomerica Inc.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
For more information about this report visit https://www.researchandmarkets.com/r/qwpxa6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
- Vitamin D Testing Market Vitamin D Testing Market Growth Rate By Region
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
